Skip to main content
. 2022 Jan 27;8:800492. doi: 10.3389/fmed.2021.800492

Figure 3.

Figure 3

Forest plots for safety outcomes with baricitinib vs. control. (A) Adverse events. (B) Serious adverse events. (C) Infection or secondary infection. RR, risk ratio; CI, confidence interval; RCT, randomized controlled trial.